Wall Street is positive on Companhia Brasileira de Distribuicao SA (CBD). On average, analysts give CBD a Buy rating. The average price target is $5.5, which means analysts expect the stock to rise by 35.80% over the next twelve months. That average ranking earns CBD an Analyst Rating of 36, which is better than 36% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating CBD a Buy today. Find out what this means to you and get the rest of the rankings on CBD!